Posts tagged monoclonal antibody medication
6 Medications That Are Used To Treat Diabetic Macular Edema
6 Medications That Are Used To Treat Diabetic Macular Edema

Diabetes is a medical condition of high blood sugar. Persistently high blood sugar can lead to health issues over time. This can include various eye problems, such as diabetic macular edema (DME). Read on to learn about the different treatment options for DME.

Read More
Biologics, Biosimilars, Eye Health, Health, Medications, Diabetes, Diabetic Macular EdemaRoss Phandiabetic macular edema, DME, diabetes, eyes, Ross Phan, expensive medications, monoclonal antibody medication, Lucentis, Byooviz, macula, VEGF inhibitors, VEGF, vascular endothelial growth factor, Avastin, bevacizumab, Eylea, aflibercept, ranibizumab, Susvimo, ranibizumab-nuna, Vabysmo, faricimab-svoa, FDA, angiopoietin-2, Ang-2, Ozurdex, dexamethasone, steroid implant, Iluvien, fluocinolone, Beovu, brolucizumabComment
FDA Approves Tezspire for Severe Asthma
FDA Approves Tezspire for Severe Asthma

Tezspire is the first and only TSLP-targeting biologic for asthma. The FDA approved it to treat any type of severe asthma. Read on to learn more about Tezspire.

Read More
Biologics, FDA, Health, Medications, AsthmaRoss Phanasthma, severe asthma, Ross Phan, drug interactions, expensive medications, monoclonal antibody medication, Tezspire, tezepelumab-ekko, asthma maintenance medication, side effects, add-on medication, thymic stromal lymphopoietin, TSLPComment
FDA Approves Byooviz to Treat 3 Eye Conditions
FDA Approves Byooviz to Treat 3 Eye Conditions

Byooviz is the first biosimilar eye medication. This biologic medication is approved to treat 3 different eye conditions. Read on to learn more about Byooviz, what it treats, and when it will be available.

Read More
FDA, Health, Medications, Eye Health, Biologics, Biosimilars, Older Adult Health, Macular DegenerationRoss Phanside effects, medical conditions, age-related macular degeneration, AMD, retinal vein occlusion, RVO, myopic choroidal neovascularization, myopic CNV, Lucentis, Byooviz, monoclonal antibody medication, Ross PhanComment